Rights and permissions
About this article
Cite this article
Retrospective analysis reveals that ceftazidime is less costly than tobramycin + ticarcillin. Inpharma Wkly. 656, 6 (1988). https://doi.org/10.1007/BF03308956
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03308956